About The Ross Prize in Molecular Medicine
The annual Ross Prize in Molecular Medicine is established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine. The winner will be an active investigator having produced innovative, paradigm-shifting research that is worthy of significant and broad attention in the field of molecular medicine. We expect this individual will continue to garner recognition in future years, and that their current accomplishments reflect a rapidly rising career trajectory of discovery and invention. The winner will receive an honorarium of $50,000 USD, travel expenses to accept the award in New York, and will present the keynote lecture at the Award Ceremony and Mini-Symposium (traditionally held during the month of June).
Nomination Timeline for The Ross Prize in Molecular Medicine
Below is a brief description of the timeline for the prize.
June 9, 2014: Opening of 2015 Award Cycle
October 3, 2014: Deadline for Nominations
October – December 31, 2014: Application Review
January 2015: Prize Winner Notification
June 2015: Third Annual Ross Prize in Molecular Medicine Symposium
Nomination Materials for The Ross Prize in Molecular Medicine Application
Candidates eligible for the prize are those nominated by a Qualified Nominator as listed above. An individual may not nominate himself or herself. Qualified Nominators are required to submit the following materials for the nomination application:
A 1 or 2 page cover letter describing the reasons for nomination (longer letters will be returned);
A 2-4 page biosketch of the nominee in the NIH format;
A full resume of the nominee; and
Reprints (PDFs) of up to 10 publications.
Advisory Committee for the The Ross Prize in Molecular Medicine The Ross Prize Advisory Committee is composed of the following six members representing The Feinstein Institute for Medical Research, the biomedical journal Molecular Medicine and the Karolinska Institutet: Christopher Czura (Molecular Medicine), Betty Diamond (Feinstein Institute for Medical Research), Peter Gregersen (Feinstein Instsitute for Medical Research), Klas Kärre (Karolinska Institutet), Lars Klareskog (Karolinska Institutet), and Kevin Tracey (Molecular Medicine). Click here for more information.